{{medical}}{{Drugbox
| Watchedfields = changed
| verifiedrevid = 443366456
| IUPAC_name = (2''R'')-2-acetamido-3-sulfanylpropanoic acid<ref>{{cite web|title=L-Cysteine, N-acetyl- - Compound Summary|url=http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=581|work=PubChem Compound|publisher=National Center for Biotechnology Information|accessdate=2012-01-09|location=USA|date=2005-03-25|at=Identification}}</ref>
| image = Acetylcysteine2DACS.svg
| width = 125
| image2 = Acetylcysteine 3D.png
| width2 =
| drug_name =
| caption =

<!-- Clinical data -->
| pronounce  = {{IPAc-en|ə|ˌ|s|ɛ|t|əl|ˈ|s|ɪ|s|t|iː|n}}
| tradename = Acetadote, Fluimucil, Mucomyst, others
| Drugs.com = {{drugs.com|monograph|acetylcysteine}}
| MedlinePlus =
| licence_EU = <!-- EMA requires brand name -->
| licence_US = Acetylcysteine
| DailyMedID = 5558a5f5-e821-473b-7d8a-5d33d09f0586
| pregnancy_AU = B2
| pregnancy_US = B
| legal_AU = S2
| legal_CA = <!-- OTC, Rx-only, Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_US = OTC 
| legal_US_comment = (by mouth), Rx-only (IV, inhalation)
| legal_CN = OTC-A
| legal_CN_comment = （仅限口服颗粒）。口服胶囊、吸入式溶液、注射液为处方药
| routes_of_administration = By mouth, injection, inhalation

<!-- Pharmacokinetic data -->
| bioavailability = 10% (Oral)<ref>{{cite book | last1 = Stockley | first1 = Robert A. | name-list-format = vanc | title = Chronic Obstructive Pulmonary Disease a Practical Guide to Management. | date = 2008 | publisher = John Wiley & Sons | location = Chichester | isbn = 9780470755280 | page = 750 | url = https://books.google.ca/books?id=y9li1geShyYC&pg=PA750 }}</ref>
| protein_bound = 50 to 83%<ref name=AHFS2015/>
| metabolism = [[肝臟|肝臟]]<ref name=AHFS2015/>
| elimination_half-life = 5.6 hours<ref name = DMI>{{cite web|title=ACETADOTE (acetylcysteine) injection, solution [Cumberland Pharmaceuticals Inc.]|work=DailyMed|publisher=Cumberland Pharmaceuticals Inc.|date=June 2013|accessdate=2013-11-08|url=http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=472f158a-5ab9-4308-8e49-1116e6ea3d39}}</ref>
| excretion = Renal (30%),<ref name=AHFS2015/> faecal (3%)

<!-- Identifiers -->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 616-91-1
| CAS_supplemental =
| ATC_prefix = R05
| ATC_suffix = CB01
| ATC_supplemental = {{ATC|S01|XA08}} {{ATC|V03|AB23}}
|  PubChem = 12035
| PubChemSubstance =
| IUPHAR_ligand =
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB06151
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
|  ChemSpiderID = 11540
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = WYQ7N0BPYC
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D00221
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 28939
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 600
| synonyms =

<!-- Chemical data -->
| chemical_formula =
| C=5 | H=9 | Ag= | As= | Au= | B= | Bi= | Br= | Cl= | Co= | F= | Fe= | Gd= | I=
| K= | Mn= | N=1 | Na= | O=3 | P= | Pt= | S=1 | Sb= | Se= | Sr= | Tc= | Zn= | charge=
| molecular_weight = 163.195
| smiles            = C/C(=N/[C@@H](CS)C(=O)O)/O
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI_comment =
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI          = 1S/C5H9NO3S/c1-3(7)6-4(2-10)5(8)9/h4,10H,2H2,1H3,(H,6,7)(H,8,9)/t4-/m0/s1
| StdInChIKey       = PWKSKIMOESPYIA-BYPYZUCNSA-N
| density = 
| melting_point = 109
| melting_high = 110
| melting_notes =<ref name=sial>{{cite web|title=N-ACETYL-L-CYSTEINE Product Information|url=https://www.sigmaaldrich.com/content/dam/sigma-aldrich/docs/Sigma-Aldrich/Product_Information_Sheet/a7250pis.pdf|website=Sigma|publisher=Sigma-aldrich|accessdate=2014-11-09|deadurl=yes|archiveurl=https://web.archive.org/web/20140611120709/http://www.sigmaaldrich.com/content/dam/sigma-aldrich/docs/Sigma-Aldrich/Product_Information_Sheet/a7250pis.pdf|archivedate=2014-06-11}}</ref>
| boiling_point = 
| boiling_notes =
| solubility = 
| specific_rotation = +5 ° (c = 3% in water)<ref name=sial/>
| sec_combustion =
}}
[[File:Acetylcystein_as_effervescent_tablet_branded_ACC_by_Sandoz.jpg|thumb]]
<!-- Definition and uses -->
'''乙醯半胱氨酸'''（Acetylcysteine），又稱為'''N-乙醯半胱氨酸'''（''N''-acetylcysteine）或'''N-乙醯-L-半胱氨酸'''（''N''-acetyl-L-cysteine），常簡稱做NAC。本品可用於治療[[对乙酰氨基酚|对乙酰氨基酚]]（普拿疼）[[对乙酰氨基酚中毒|中毒]]，且可用於解化過濃的[[黏液|黏液]]，因此可用於緩解[[囊腫性纖維化|囊腫性纖維化]]及[[慢性阻塞性肺病|慢性阻塞性肺病]]的症狀<ref name=AHFS2015>{{cite web|title=Acetylcysteine|url=http://www.drugs.com/monograph/acetylcysteine.html|publisher=The American Society of Health-System Pharmacists|accessdate=2015-08-22}}</ref>。本品可經[[靜脈注射|靜脈注射]]、口服，或吸入途徑給藥<ref name=AHFS2015/>。

<!-- Side effects and mechanism -->
常見副作用包含惡心或嘔吐，但此類副作用以口服劑為主。其他副作用還包含皮膚[[紅斑|紅斑]]、搔癢。較嚴重的副作用則可能發生非免疫型的[[全身型過敏性反應|全身型過敏性反應]]。妊娠期間用藥目前顯示安全。本品的作用機轉是藉由提升體內的[[谷胱甘肽|谷胱甘肽]]濃度， 藉此與普拿疼的有害代謝產物結合解毒<ref name=AHFS2015/>。

<!-- History, society and culture -->
乙醯半胱氨酸最初於1960年獲得專利，且於1968年取得執照<ref>{{cite book|url=https://books.google.ca/books?id=FjKfqkaKkAAC&pg=PA544|title=Analogue-Based Drug Discovery|last2=Ganellin|first2=C. Robin|date=2006|publisher=Wiley-VCH|isbn=9783527607495|location=Weinheim|page=544|last1=Fischer|first1=János|name-list-format=vanc}}</ref>。本品列名於[[世界衛生組織基本藥物標準清單|世界衛生組織基本藥物標準清單]]之中，為基礎[[醫療系統|醫療系統]]必備藥物之一<ref name="WHO19th">{{cite web|url=http://www.who.int/medicines/publications/essentialmedicines/EML_2015_FINAL_amended_NOV2015.pdf?ua=1|title=WHO Model List of Essential Medicines (19th List)|accessdate=2016-12-08|date=April 2015|work=World Health Organization}}</ref>。乙醯半胱氨酸屬於[[通用名藥物|通用名藥物]]，且價格不貴<ref>{{cite book|url=https://books.google.ca/books?id=oeYjAwAAQBAJ&pg=PT44|title=Top 100 drugs : clinical pharmacology and practical prescribing|date=2014|isbn=9780702055157|page=Acetylcysteine|last1=Baker|first1=Emma|name-list-format=vanc}}</ref>。

==参考文献==
{{reflist}}

== 外部連結 ==
* [http://druginfo.nlm.nih.gov/drugportal/dpdirect.jsp?name=Acetylcysteine U.S. National Library of Medicine: Drug Information Portal - Acetylcysteine]

{{Antioxidants}}
{{Antidotes}}
{{Portal bar|醫學}}

[[Category:抗氧化剂|Category:抗氧化剂]]
[[Category:解毒剂|Category:解毒剂]]
[[Category:硫醇|硫醇]]
[[Category:氨基酸衍生物|Category:氨基酸衍生物]]
[[Category:世界卫生组织基本药物|Category:世界卫生组织基本药物]]
[[Category:赋形剂|Category:赋形剂]]
[[Category:双相障碍治疗|Category:双相障碍治疗]]
[[Category:乙酰胺|Category:乙酰胺]]